Global Information
회사소개 | 문의 | 비교리스트

표적요법 시장 : 종류별, 용도별, 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Targeted Therapy Market, by Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045549
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,792,000 PDF (Single User License)
US $ 7,000 ₩ 9,011,000 PDF (Multi User License)
US $ 10,000 ₩ 12,873,000 PDF (Enterprise User License)


표적요법 시장 : 종류별, 용도별, 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Targeted Therapy Market, by Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

암 치료를 위한 첨단 치료법에 관한 인식 확산에 의해 정밀 종양학을 위한 약제 개발이 촉진되어 표적요법 시장 성장이 기대되고 있습니다. 시장의 주요 기업은 제품 파이프라인 확대에 주력하고 있으며, 시장에서의 지위를 강화하고 있는 점이 시장 성장을 촉진하고 있습니다.

세계의 표적요법(Targeted Therapy) 시장에 대해 조사 분석했으며, 시장 역학, COVID-19의 영향 분석, 종류·용도·유통 채널·지역별 시장 분석, 경쟁 상황을 제공합니다.

목차

제1장 조사 목적과 가정

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약
    • 시장 개요 : 종류별
    • 시장 개요 : 용도별
    • 시장 개요 : 유통 채널별
    • 시장 개요 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제 및 동향 분석

  • 표적요법의 연구개발(R&D) 활동
  • CBD와 THC의 의료 용도
  • 영향 분석
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 주요 발전
  • 전략적 제휴와 계약
  • 규제 시나리오
  • PEST 분석
  • 표적요법의 새로운 용도

제4장 세계의 표적요법 시장 : COVID-19 팬데믹의 영향

  • COVID-19 역학
  • 수요와 공급 분석
  • 주요 발전

제5장 세계의 표적요법 시장 : 종류별(2017-2028년(100만 달러))

  • 저분자 의약품
  • 단일클론항체

제6장 세계의 표적요법 시장 : 용도별(2017-2028년(100만 달러))

  • 유방암
  • 대장암
  • 백혈병
  • 폐암
  • 림프종
  • 신장암
  • 기타

제7장 세계의 표적요법 시장 : 유통 채널별(2017-2028년(100만 달러))

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 표적요법 시장 : 지역별(2017-2028년(100만 달러))

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 상황

  • 히트맵 분석
  • 시장 점유율 분석
    • Amgen Inc.
    • GlaxoSmithKline plc
    • Sanofi
    • Takeda Pharmaceutical Company Limited
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd
    • AstraZeneca
    • Seagen Inc.
    • Bayer AG
    • Bristol Myers Squibb
  • 애널리스트의 견해

제10장 섹션

KSM 22.01.26

Targeted therapy is used individually and in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy. It is the foundation of precision medicine. Targeted therapies are divided into two classes such as small molecule medicines and monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab. Most types of targeted therapies help to treat cancer by interfering with specific proteins that help tumors grow and spread throughout the body. They treat cancer in many ways such as helps the immune system destroy cancer cells, stop cancer cells from growing, stop signals that help form blood vessels, cause cancer cell death, deliver cell-killing substances to cancer cells, starve cancer of the hormones it needs to grow. Targeted therapies is approved by the U.S. Food and Drug Administration for various types of cancers. This offers significant benefits to treat the cancer such as alter proteins within cancer cells that cause those cells to die, prevent new blood vessels from forming, which cuts off blood supply to tumor, and others. One of the major advantage of targeted therapy is it helps to reduce cancer treatment-related side effects and improved outcomes.

Market Dynamics

Increase in awareness regarding the advanced therapeutics to treat cancer leads to facilitate drug development in precision oncology is likely expected to boost the growth of market. For instance, in May 2021, the U.S. Food and Drug Administration had approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer. Furthermore, key players operating in the market are engaged in focusing on expanding the products pipeline and thereby strengthening the market position. This in turn to drive the growth of market. For instance, Xilio Therapeutics, a biotechnology company entered into a clinical trial collaboration and supply agreement with Merck to evaluate XTX101, Xilio's engineered tumor-selective Fc-enhanced, anti-CTLA-4 monoclonal antibody (mAb) product candidate, in combination with KEYTRUDA.

Key features of the study:

  • This report provides an in-depth analysis of the global targeted therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global targeted therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Amgen Inc., GlaxoSmithKline plc, Sanofi, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Seagen Inc., Bayer AG, and Bristol Myers Squibb
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global targeted therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global targeted therapy market

Detailed Segmentation:

  • Global Targeted Therapy Market, By Type :
    • Small Molecule Medicines
    • Monoclonal Antibodies
  • Global Targeted Therapy Market, By Application:
    • Breast Cancer
    • Colorectal Cancer
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Renal Cancer
    • Others
  • Global Targeted Therapy Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Targeted Therapy Market, By Region:
    • North America
      • By Type
      • Small Molecule Medicines
      • Monoclonal Antibodies
      • By Application
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Renal Cancer
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Type
      • Small Molecule Medicines
      • Monoclonal Antibodies
      • By Application
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Renal Cancer
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type
      • Small Molecule Medicines
      • Monoclonal Antibodies
      • By Application
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Renal Cancer
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type
      • Small Molecule Medicines
      • Monoclonal Antibodies
      • By Application
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Renal Cancer
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type
      • Small Molecule Medicines
      • Monoclonal Antibodies
      • By Application
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Renal Cancer
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type
      • Small Molecule Medicines
      • Monoclonal Antibodies
      • By Application
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma
      • Renal Cancer
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Amgen Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
    • Sanofi
    • Takeda Pharmaceutical Company Limited
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd
    • AstraZeneca
    • Seagen Inc.
    • Bayer AG
    • Bristol Myers Squibb

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Research & Development (R&D) Activities in Targeted Therapy
  • Medical Uses Of CBD vs THC
  • Impact Analysis
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Key Developments
  • Strategic Collaborations & Agreements
  • Regulatory Scenario
  • PEST Analysis
  • Emerging use of Targeted Therapies

4. Global Targeted Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply and Demand Analysis
  • Key Developments

5. Global Targeted Therapy Market, By Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Small Molecule Medicines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Targeted Therapy Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Leukemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Renal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Targeted Therapy Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Targeted Therapy Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2028
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • GlaxoSmithKline plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Seagen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Bristol Myers Squibb
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About Us
Back to Top
전화 문의
F A Q